Lenvatinib Mesylate and Reclipsen
Determining the interaction of Lenvatinib Mesylate and Reclipsen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: desogestrel / ethinyl estradiol
Brand name: Azurette, Cyclessa, Desogen, Isibloom, Kariva, Mircette, Reclipsen, Apri, Bekyree, Caziant, Ortho-Cept, Solia, Cesia, Cyred
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Recombinate
- Lenvatinib Mesylate-Recombinate recombinant
- Lenvatinib Mesylate-Recombivax
- Lenvatinib Mesylate-Recombivax HB
- Lenvatinib Mesylate-Recombivax HB Adult
- Lenvatinib Mesylate-Recombivax HB Dialysis Formulation
- Reclipsen-Lenvima
- Reclipsen-Lenvima (14 MG Daily Dose)
- Reclipsen-Lenvima (18 MG Daily Dose)
- Reclipsen-Lenvima (20 MG Daily Dose)
- Reclipsen-Lenvima (24 MG Daily Dose)
- Reclipsen-Lenvima (8 MG Daily Dose)